Q2-rapport
12 dagar sedan‧48min
Orderdjup
Antal
Köp
0
Sälj
Antal
0
Senaste avslut
| Tid | Pris | Antal | Köpare | Säljare |
|---|---|---|---|---|
| - | - | - | - |
Högst
6,94VWAP
Lägst
6,43OmsättningAntal
7,2 1 068 356
VWAP
Högst
6,94Lägst
6,43OmsättningAntal
7,2 1 068 356
Mäklarstatistik
Ingen data hittades
Företagshändelser
| Nästa händelse | |
|---|---|
Kalender är inte tillgänglig | |
| Tidigare händelser | ||
|---|---|---|
| 2025 Q2-rapport | 5 aug. | |
| 2025 Årsstämma | 5 juni | |
| 2025 Q1-rapport | 7 maj | |
| 2024 Q4-rapport | 4 mars | |
| 2024 Årsrapport | 4 mars |
Data hämtas från Morningstar, Quartr
Kunder har även besökt
Shareville
Delta i diskussionerna på SharevilleFå inspiration från tusentals portföljer och diskutera med andra duktiga investerare.
Logga in
31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://www.google.co.uk/amp/s/marketingsentinel.com/2020/11/23/evolus-inc-nasdaqeols-stock-forecast-for-2020-bullish-signs-point-to-35-per-share/amp/ Evolus, Inc. (NASDAQ:EOLS) Stock Forecast for 2020: Bullish Signs Point to $35 per Share Eric Enderson Eric Enderson 4 hours ago In the latest trading session, 1,132,271 Evolus, Inc.(NASDAQ:EOLS) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $4 changing hands around $0.59 or 0.173, the market valuation stands at $135Million. EOLS’s current price is a discount, trading about -266% off its 52-week high of $14.64. The share price had its 52-week low at $2.85, which suggests the current value is an impressive 28.75% up since. When we look at Evolus, Inc.’s average trading volume, we note the 10-day average is 596Million shares, with the 3-month average coming to 462.68 Million. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Analysts give the Evolus, Inc. (EOLS) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2.2. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 2 recommended EOLS as a Hold, 5 felt it is a Buy and none rated the premier stock as Underweight. Evolus, Inc.’s EPS for the quarter is expected to be -$0.2. Evolus, Inc. (NASDAQ:EOLS) trade information Instantly EOLS is in green as seen in intraday trades today with action 17.3%, the outlook over the past five days has been green. The jump to weekly highs of $4.21-4 on Friday, Nov 20 added 4.99% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.6713, with the 5-day performance at 0.1364 in the green. However, in the 30-day time frame, Evolus, Inc. (NASDAQ:EOLS) is 0.0178 up. Looking at the short shares, we see there were 3.75 Million shares sold at short interest cover period of 0.01 days. The consensus price target for the stock as assigned by Wall Street analysts is $10.63, meaning bulls need an upside of 165.75% from its current market value. According to analyst projections, EOLS’s forecast low is $4 with $35 as the target high. To hit the forecast high, the stock’s price needs a +775% upsurge from its current level, while the stock would need to tank 0% for it to hit the projected low. Evolus, Inc. (EOLS) estimates and forecasts Data shows that the Evolus, Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -13.23% over the past 6 months, a -48.9% in annual growth rate that is considerably lower than the industry average of 10.2%. Moreover, the firm has looked to higher expectations by upgrading its fiscal year 2020 revenue estimates. Evolus, Inc. estimates its current quarter revenue will rise +57.4%, while the growth in revenue is estimated to hit 86.7% for the next quarter. Year-over-year growth is forecast to reach 66% up from the last financial year. Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of $21.97 Million. 1 analysts are of the opinion that Evolus, Inc.’s revenue for the quarter ending 44256 will be $23Million. The company’s sales revenue for the current and next quarters a year ago was $19.45 Million and $10.5 Million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13%. The estimates for the next quarter sales put growth at 119.1%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2020 estimates are for Evolus, Inc. earnings to decrease by -66%, but the outlook for the next 5-year period is at 16.5% per year. Evolus, Inc. (NASDAQ:EOLS)’s Major holders If we look at who the major shareholders are, we find that insiders hold 33.99% of Evolus, Inc. shares while 22.95% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.77%. There are 126 institutions holding the Evolus, Inc. stock share, with Blackrock Inc. the top institutional holder. As of 44103, the company held 5.25% of the shares, roughly 1.77 Million EOLS shares worth $6.93 Million. Schroder Investment Management Group holds the second largest percentage of outstanding shares, with 4.03% or 1.36 Million shares worth $5.32 Million as of 44103.- 31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://newsheater.com/2020/11/23/highlights-from-the-ratings-and-financial-report-for-evolus-inc-eols/ Highlights from the Ratings and Financial Report for Evolus Inc. (EOLS) By Denise Gardner - November 23, 2020 Evolus Inc. (NASDAQ:EOLS) went up by 17.30% from its latest closing price compared to the recent 1-year high of $14.64. The company’s stock price has collected 13.64% of gains in the last five trading sessions. Press Release reported 13 hours ago that Evolus Shareholder Notice Is It Worth Investing in Evolus Inc. (NASDAQ :EOLS) Right Now? Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Evolus Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 1 as “sell.” Continue Reading The average price from analysts is $10.63. EOLS currently public float of 22.28M and currently shorts hold a 16.84% ratio of that float. Today, the average trading volume of EOLS was 445.86K shares. EOLS’s Market Performance EOLS stocks went up by 13.64% for the week, with a monthly jump of 16.28% and a quarterly performance of 17.30%, while its annual performance rate touched -71.37%. The volatility ratio for the week stands at 10.33% while the volatility levels for the past 30 days are set at 7.95% for Evolus Inc.. The simple moving average for the period of the last 20 days is 21.30% for EOLS stocks with a simple moving average of -12.59% for the last 200 days. Analysts’ Opinion of EOLS Many brokerage firms have already submitted their reports for EOLS stocks, with Mizuho repeating the rating for EOLS by listing it as a “Neutral.” The predicted price for EOLS in the upcoming period, according to Mizuho is $3 based on the research report published on July 07th of the current year 2020. SVB Leerink gave a rating of “Outperform” to EOLS, setting the target price at $25 in the report published on November 26th of the previous year. EOLS Trading at 7.18% from the 50-Day Moving Average After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.68% of loss for the given period. Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 10.33%, as shares surge +13.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.31% upper at present. During the last 5 trading sessions, EOLS rose by +13.64%, which changed the moving average for the period of 200-days by -58.68% in comparison to the 20-day moving average, which settled at $3.32. In addition, Evolus Inc. saw -67.13% in overturn over a single year, with a tendency to cut further losses. Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price. Stock Fundamentals for EOLS Current profitability levels for the company are sitting at: -271.40 for the present operating margin +65.22 for the gross margin The net margin for Evolus Inc. stands at -257.79. The total capital return value is set at -68.37, while invested capital returns managed to touch -65.22. Equity return is now at value -121.10, with -30.90 for asset returns. Based on Evolus Inc. (EOLS), the company’s capital structure generated 121.51 points at debt to equity in total, while total debt to capital is 54.85. Total debt to assets is 40.15, with long-term debt to equity ratio resting at 120.00. Finally, the long-term debt to capital ratio is 54.17. When we switch over and look at the enterrpise to sales, we see a ratio of 8.89, with the company’s debt to enterprise value settled at 0.31. The receivables turnover for the company is 6.55 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.23.31 jan. 2022 · Ändrad31 jan. 2022 · Ändrad** That’s What makes things interesting Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price.
Kommentarerna ovan kommer från användare på Nordnets sociala nätverk Shareville och har varken redigerats eller på förhand granskats av Nordnet. Det innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna eller eventuella felaktigheter i automatiska översättningar.
Nyheter & Analyser
Det finns för närvarande inga nyheter
Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.
Q2-rapport
12 dagar sedan‧48min
Nyheter & Analyser
Det finns för närvarande inga nyheter
Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.
Shareville
Delta i diskussionerna på SharevilleFå inspiration från tusentals portföljer och diskutera med andra duktiga investerare.
Logga in
- 31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://www.google.co.uk/amp/s/marketingsentinel.com/2020/11/23/evolus-inc-nasdaqeols-stock-forecast-for-2020-bullish-signs-point-to-35-per-share/amp/ Evolus, Inc. (NASDAQ:EOLS) Stock Forecast for 2020: Bullish Signs Point to $35 per Share Eric Enderson Eric Enderson 4 hours ago In the latest trading session, 1,132,271 Evolus, Inc.(NASDAQ:EOLS) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $4 changing hands around $0.59 or 0.173, the market valuation stands at $135Million. EOLS’s current price is a discount, trading about -266% off its 52-week high of $14.64. The share price had its 52-week low at $2.85, which suggests the current value is an impressive 28.75% up since. When we look at Evolus, Inc.’s average trading volume, we note the 10-day average is 596Million shares, with the 3-month average coming to 462.68 Million. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Analysts give the Evolus, Inc. (EOLS) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2.2. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 2 recommended EOLS as a Hold, 5 felt it is a Buy and none rated the premier stock as Underweight. Evolus, Inc.’s EPS for the quarter is expected to be -$0.2. Evolus, Inc. (NASDAQ:EOLS) trade information Instantly EOLS is in green as seen in intraday trades today with action 17.3%, the outlook over the past five days has been green. The jump to weekly highs of $4.21-4 on Friday, Nov 20 added 4.99% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.6713, with the 5-day performance at 0.1364 in the green. However, in the 30-day time frame, Evolus, Inc. (NASDAQ:EOLS) is 0.0178 up. Looking at the short shares, we see there were 3.75 Million shares sold at short interest cover period of 0.01 days. The consensus price target for the stock as assigned by Wall Street analysts is $10.63, meaning bulls need an upside of 165.75% from its current market value. According to analyst projections, EOLS’s forecast low is $4 with $35 as the target high. To hit the forecast high, the stock’s price needs a +775% upsurge from its current level, while the stock would need to tank 0% for it to hit the projected low. Evolus, Inc. (EOLS) estimates and forecasts Data shows that the Evolus, Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -13.23% over the past 6 months, a -48.9% in annual growth rate that is considerably lower than the industry average of 10.2%. Moreover, the firm has looked to higher expectations by upgrading its fiscal year 2020 revenue estimates. Evolus, Inc. estimates its current quarter revenue will rise +57.4%, while the growth in revenue is estimated to hit 86.7% for the next quarter. Year-over-year growth is forecast to reach 66% up from the last financial year. Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of $21.97 Million. 1 analysts are of the opinion that Evolus, Inc.’s revenue for the quarter ending 44256 will be $23Million. The company’s sales revenue for the current and next quarters a year ago was $19.45 Million and $10.5 Million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13%. The estimates for the next quarter sales put growth at 119.1%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2020 estimates are for Evolus, Inc. earnings to decrease by -66%, but the outlook for the next 5-year period is at 16.5% per year. Evolus, Inc. (NASDAQ:EOLS)’s Major holders If we look at who the major shareholders are, we find that insiders hold 33.99% of Evolus, Inc. shares while 22.95% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.77%. There are 126 institutions holding the Evolus, Inc. stock share, with Blackrock Inc. the top institutional holder. As of 44103, the company held 5.25% of the shares, roughly 1.77 Million EOLS shares worth $6.93 Million. Schroder Investment Management Group holds the second largest percentage of outstanding shares, with 4.03% or 1.36 Million shares worth $5.32 Million as of 44103.
- 31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://newsheater.com/2020/11/23/highlights-from-the-ratings-and-financial-report-for-evolus-inc-eols/ Highlights from the Ratings and Financial Report for Evolus Inc. (EOLS) By Denise Gardner - November 23, 2020 Evolus Inc. (NASDAQ:EOLS) went up by 17.30% from its latest closing price compared to the recent 1-year high of $14.64. The company’s stock price has collected 13.64% of gains in the last five trading sessions. Press Release reported 13 hours ago that Evolus Shareholder Notice Is It Worth Investing in Evolus Inc. (NASDAQ :EOLS) Right Now? Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Evolus Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 1 as “sell.” Continue Reading The average price from analysts is $10.63. EOLS currently public float of 22.28M and currently shorts hold a 16.84% ratio of that float. Today, the average trading volume of EOLS was 445.86K shares. EOLS’s Market Performance EOLS stocks went up by 13.64% for the week, with a monthly jump of 16.28% and a quarterly performance of 17.30%, while its annual performance rate touched -71.37%. The volatility ratio for the week stands at 10.33% while the volatility levels for the past 30 days are set at 7.95% for Evolus Inc.. The simple moving average for the period of the last 20 days is 21.30% for EOLS stocks with a simple moving average of -12.59% for the last 200 days. Analysts’ Opinion of EOLS Many brokerage firms have already submitted their reports for EOLS stocks, with Mizuho repeating the rating for EOLS by listing it as a “Neutral.” The predicted price for EOLS in the upcoming period, according to Mizuho is $3 based on the research report published on July 07th of the current year 2020. SVB Leerink gave a rating of “Outperform” to EOLS, setting the target price at $25 in the report published on November 26th of the previous year. EOLS Trading at 7.18% from the 50-Day Moving Average After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.68% of loss for the given period. Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 10.33%, as shares surge +13.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.31% upper at present. During the last 5 trading sessions, EOLS rose by +13.64%, which changed the moving average for the period of 200-days by -58.68% in comparison to the 20-day moving average, which settled at $3.32. In addition, Evolus Inc. saw -67.13% in overturn over a single year, with a tendency to cut further losses. Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price. Stock Fundamentals for EOLS Current profitability levels for the company are sitting at: -271.40 for the present operating margin +65.22 for the gross margin The net margin for Evolus Inc. stands at -257.79. The total capital return value is set at -68.37, while invested capital returns managed to touch -65.22. Equity return is now at value -121.10, with -30.90 for asset returns. Based on Evolus Inc. (EOLS), the company’s capital structure generated 121.51 points at debt to equity in total, while total debt to capital is 54.85. Total debt to assets is 40.15, with long-term debt to equity ratio resting at 120.00. Finally, the long-term debt to capital ratio is 54.17. When we switch over and look at the enterrpise to sales, we see a ratio of 8.89, with the company’s debt to enterprise value settled at 0.31. The receivables turnover for the company is 6.55 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.23.31 jan. 2022 · Ändrad31 jan. 2022 · Ändrad** That’s What makes things interesting Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price.
Kommentarerna ovan kommer från användare på Nordnets sociala nätverk Shareville och har varken redigerats eller på förhand granskats av Nordnet. Det innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna eller eventuella felaktigheter i automatiska översättningar.
Orderdjup
Antal
Köp
0
Sälj
Antal
0
Senaste avslut
| Tid | Pris | Antal | Köpare | Säljare |
|---|---|---|---|---|
| - | - | - | - |
Högst
6,94VWAP
Lägst
6,43OmsättningAntal
7,2 1 068 356
VWAP
Högst
6,94Lägst
6,43OmsättningAntal
7,2 1 068 356
Mäklarstatistik
Ingen data hittades
Kunder har även besökt
Företagshändelser
| Nästa händelse | |
|---|---|
Kalender är inte tillgänglig | |
| Tidigare händelser | ||
|---|---|---|
| 2025 Q2-rapport | 5 aug. | |
| 2025 Årsstämma | 5 juni | |
| 2025 Q1-rapport | 7 maj | |
| 2024 Q4-rapport | 4 mars | |
| 2024 Årsrapport | 4 mars |
Data hämtas från Morningstar, Quartr
Q2-rapport
12 dagar sedan‧48min
Nyheter & Analyser
Det finns för närvarande inga nyheter
Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.
Företagshändelser
| Nästa händelse | |
|---|---|
Kalender är inte tillgänglig | |
| Tidigare händelser | ||
|---|---|---|
| 2025 Q2-rapport | 5 aug. | |
| 2025 Årsstämma | 5 juni | |
| 2025 Q1-rapport | 7 maj | |
| 2024 Q4-rapport | 4 mars | |
| 2024 Årsrapport | 4 mars |
Data hämtas från Morningstar, Quartr
Shareville
Delta i diskussionerna på SharevilleFå inspiration från tusentals portföljer och diskutera med andra duktiga investerare.
Logga in
- 31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://www.google.co.uk/amp/s/marketingsentinel.com/2020/11/23/evolus-inc-nasdaqeols-stock-forecast-for-2020-bullish-signs-point-to-35-per-share/amp/ Evolus, Inc. (NASDAQ:EOLS) Stock Forecast for 2020: Bullish Signs Point to $35 per Share Eric Enderson Eric Enderson 4 hours ago In the latest trading session, 1,132,271 Evolus, Inc.(NASDAQ:EOLS) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $4 changing hands around $0.59 or 0.173, the market valuation stands at $135Million. EOLS’s current price is a discount, trading about -266% off its 52-week high of $14.64. The share price had its 52-week low at $2.85, which suggests the current value is an impressive 28.75% up since. When we look at Evolus, Inc.’s average trading volume, we note the 10-day average is 596Million shares, with the 3-month average coming to 462.68 Million. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Analysts give the Evolus, Inc. (EOLS) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2.2. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 2 recommended EOLS as a Hold, 5 felt it is a Buy and none rated the premier stock as Underweight. Evolus, Inc.’s EPS for the quarter is expected to be -$0.2. Evolus, Inc. (NASDAQ:EOLS) trade information Instantly EOLS is in green as seen in intraday trades today with action 17.3%, the outlook over the past five days has been green. The jump to weekly highs of $4.21-4 on Friday, Nov 20 added 4.99% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.6713, with the 5-day performance at 0.1364 in the green. However, in the 30-day time frame, Evolus, Inc. (NASDAQ:EOLS) is 0.0178 up. Looking at the short shares, we see there were 3.75 Million shares sold at short interest cover period of 0.01 days. The consensus price target for the stock as assigned by Wall Street analysts is $10.63, meaning bulls need an upside of 165.75% from its current market value. According to analyst projections, EOLS’s forecast low is $4 with $35 as the target high. To hit the forecast high, the stock’s price needs a +775% upsurge from its current level, while the stock would need to tank 0% for it to hit the projected low. Evolus, Inc. (EOLS) estimates and forecasts Data shows that the Evolus, Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -13.23% over the past 6 months, a -48.9% in annual growth rate that is considerably lower than the industry average of 10.2%. Moreover, the firm has looked to higher expectations by upgrading its fiscal year 2020 revenue estimates. Evolus, Inc. estimates its current quarter revenue will rise +57.4%, while the growth in revenue is estimated to hit 86.7% for the next quarter. Year-over-year growth is forecast to reach 66% up from the last financial year. Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of $21.97 Million. 1 analysts are of the opinion that Evolus, Inc.’s revenue for the quarter ending 44256 will be $23Million. The company’s sales revenue for the current and next quarters a year ago was $19.45 Million and $10.5 Million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13%. The estimates for the next quarter sales put growth at 119.1%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2020 estimates are for Evolus, Inc. earnings to decrease by -66%, but the outlook for the next 5-year period is at 16.5% per year. Evolus, Inc. (NASDAQ:EOLS)’s Major holders If we look at who the major shareholders are, we find that insiders hold 33.99% of Evolus, Inc. shares while 22.95% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.77%. There are 126 institutions holding the Evolus, Inc. stock share, with Blackrock Inc. the top institutional holder. As of 44103, the company held 5.25% of the shares, roughly 1.77 Million EOLS shares worth $6.93 Million. Schroder Investment Management Group holds the second largest percentage of outstanding shares, with 4.03% or 1.36 Million shares worth $5.32 Million as of 44103.
- 31 jan. 2022 · Ändrad31 jan. 2022 · Ändradhttps://newsheater.com/2020/11/23/highlights-from-the-ratings-and-financial-report-for-evolus-inc-eols/ Highlights from the Ratings and Financial Report for Evolus Inc. (EOLS) By Denise Gardner - November 23, 2020 Evolus Inc. (NASDAQ:EOLS) went up by 17.30% from its latest closing price compared to the recent 1-year high of $14.64. The company’s stock price has collected 13.64% of gains in the last five trading sessions. Press Release reported 13 hours ago that Evolus Shareholder Notice Is It Worth Investing in Evolus Inc. (NASDAQ :EOLS) Right Now? Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Evolus Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 1 as “sell.” Continue Reading The average price from analysts is $10.63. EOLS currently public float of 22.28M and currently shorts hold a 16.84% ratio of that float. Today, the average trading volume of EOLS was 445.86K shares. EOLS’s Market Performance EOLS stocks went up by 13.64% for the week, with a monthly jump of 16.28% and a quarterly performance of 17.30%, while its annual performance rate touched -71.37%. The volatility ratio for the week stands at 10.33% while the volatility levels for the past 30 days are set at 7.95% for Evolus Inc.. The simple moving average for the period of the last 20 days is 21.30% for EOLS stocks with a simple moving average of -12.59% for the last 200 days. Analysts’ Opinion of EOLS Many brokerage firms have already submitted their reports for EOLS stocks, with Mizuho repeating the rating for EOLS by listing it as a “Neutral.” The predicted price for EOLS in the upcoming period, according to Mizuho is $3 based on the research report published on July 07th of the current year 2020. SVB Leerink gave a rating of “Outperform” to EOLS, setting the target price at $25 in the report published on November 26th of the previous year. EOLS Trading at 7.18% from the 50-Day Moving Average After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.68% of loss for the given period. Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 10.33%, as shares surge +13.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.31% upper at present. During the last 5 trading sessions, EOLS rose by +13.64%, which changed the moving average for the period of 200-days by -58.68% in comparison to the 20-day moving average, which settled at $3.32. In addition, Evolus Inc. saw -67.13% in overturn over a single year, with a tendency to cut further losses. Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price. Stock Fundamentals for EOLS Current profitability levels for the company are sitting at: -271.40 for the present operating margin +65.22 for the gross margin The net margin for Evolus Inc. stands at -257.79. The total capital return value is set at -68.37, while invested capital returns managed to touch -65.22. Equity return is now at value -121.10, with -30.90 for asset returns. Based on Evolus Inc. (EOLS), the company’s capital structure generated 121.51 points at debt to equity in total, while total debt to capital is 54.85. Total debt to assets is 40.15, with long-term debt to equity ratio resting at 120.00. Finally, the long-term debt to capital ratio is 54.17. When we switch over and look at the enterrpise to sales, we see a ratio of 8.89, with the company’s debt to enterprise value settled at 0.31. The receivables turnover for the company is 6.55 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.23.31 jan. 2022 · Ändrad31 jan. 2022 · Ändrad** That’s What makes things interesting Insider Trading Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 39,442 shares at the price of $10.71 back on Jan 07. After this action, Avelar Rui now owns 70,802 shares of Evolus Inc., valued at $422,282 using the latest closing price.
Kommentarerna ovan kommer från användare på Nordnets sociala nätverk Shareville och har varken redigerats eller på förhand granskats av Nordnet. Det innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna eller eventuella felaktigheter i automatiska översättningar.
Orderdjup
Antal
Köp
0
Sälj
Antal
0
Senaste avslut
| Tid | Pris | Antal | Köpare | Säljare |
|---|---|---|---|---|
| - | - | - | - |
Högst
6,94VWAP
Lägst
6,43OmsättningAntal
7,2 1 068 356
VWAP
Högst
6,94Lägst
6,43OmsättningAntal
7,2 1 068 356
Mäklarstatistik
Ingen data hittades